Nivaan Care is a leading healthcare start-up headquartered in New Delhi. Nivaan Care raised funds in the Series A round of $7 million. This was a major capital injection led by Sorin Investments and the active involvement of the company’s existing investors, such as the W Health Ventures, Endiya Partners and Rebright Partners. The investment is a significant milestone for the startup that was established in 2023 by Nivesh Khandelwal and Vishwas Singh with the idea to solve the frequently underestimated issues of chronic pain management in India.

Vision and multidisciplinary care model

The investment is after a preceding seed round in February of last year, which saw the company raise $4.25 million. Through this new Series A round, Nivaan Care plans to increase its expansion by adding more clinics in different cities in India and enhancing its clinical and operating infrastructure. The vision of the company is to establish a strong structure that facilitates specialised treatment of patients with underlying conditions like back, knee, and neck pain to provide an alternative to the long-standing, disjointed healthcare environment.

Nivaan Care is a multidisciplinary chain of pain management clinics with a single-specialty in a single chain. This model is special since the knowledge of pain physicians, physiotherapists, and care coordinators is united under one roof. Through the integration of these various disciplines, the startup will be able to provide non-surgical and minimally invasive procedures, which will specifically address the needs of the individual patient. This strategy is meant to bridge the gap in the Indian healthcare market where patients are in a dilemma of being left to basic physiotherapy that might not be adequate, and invasive surgeries that they might not want.

The clinical model employed by the startup focuses on evidence-based care. It targets the mid-tier of healthcare, where minimally invasive procedures would be used to bring relief to patients with chronic pain. To date, Nivaan Care has been an operationally successful company, having served more than 40,000 patients in consultations and around 5,000 patients in minimally invasive operations. At this point, the company has established itself in some of the key Indian centres such as Delhi-NCR, Mumbai, Jaipur, and Lucknow, which demonstrates the scalability of its specialised service.

Strategic expansion and company offerings

The funds collected during the present Series A round will be significant in enabling Nivaan Care to grow its activities in a responsible manner without losing a patient-first culture. The investment, according to Co-founder and CEO Nivesh Khandelwal, gives the resources needed to increase the geographic presence of the company and enhance its clinical capacity. The company can achieve this by becoming a household name in the speciality healthcare industry by being creative about the pain management solutions that target the Indian population.

Besides enhancing its presence in the current markets, Nivaan Care is looking at entering new key markets. According to co-founder and COO Vishwas Singh, the funding would allow the company to expand to cities such as Bengaluru and develop the operational foundation it needs to subsequently expand to a few more cities in a satrapy. This strategic expansion is expected to target more people and bring about a specialisation of pain management closer to the millions of Indians who have no clear route to recovery at present.

The need to have a specific pain management platform is also emphasised in the figures related to chronic pain in India. Statistics indicate that almost every fifth adult in the nation experiences chronic pain, but care delivery is extremely uneven. 

The majority of patients tend to alternate between short-term solutions and long-lasting surgical procedures without being able to balance effective treatments. Nivaan Care aims to address this fragmentation by offering a multidisciplinary intervention that is well-organised, focused on the long-term well-being of the patient, and mobility.

The company provides a highly valuable service to people who prefer a non-surgical approach in the management of their health without the threats and the post-surgery recovery time of having big operations. Minimal invasive procedures are focused on in order to provide patients with high-quality clinical outcomes in a more efficient and less stressful way. As the startup expands its infrastructure and moves into new markets, it is still improving its model in order to meet the more complex needs of the Indian population.

Conclusion

The successful Series A round of funding, led by Sorin Investments, is a major confirmation of the business model of Nivaan Care and how it is likely to change the speciality healthcare environment in India. The innovative multidisciplinary clinics will further position the company well in filling the gap in managing chronic pain with new capital of $7 million. With an increased emphasis on evidence-based medical solutions and diversifying into high-demand markets such as Bengaluru, Nivaan Care will seek to offer a long-overdue intermediate level of care to millions of patients.